Keyphrases
Methicillin-resistant Staphylococcus Aureus
77%
COVID-19
75%
Pseudomonas Aeruginosa (P. aeruginosa)
68%
Japan
61%
Pneumonia
60%
Streptococcus Pneumoniae
50%
Azithromycin
47%
Murine Model
46%
Airway Epithelial Cells
45%
Lung
43%
β-lactamase
42%
In Vivo Efficacy
41%
Mucin 5AC (MUC5AC)
40%
Mouse Model
39%
Quantitative PCR
39%
Risk Factors
37%
Meropenem
36%
Vancomycin
34%
Haemophilus Influenzae
32%
Nagasaki
30%
Infectious Diseases
29%
Klebsiella Pneumoniae (K. pneumoniae)
28%
Metallo-β-lactamase
27%
Chronic Pulmonary Aspergillosis
26%
Macrolides
26%
S. Pneumoniae
25%
Hematogenous
25%
Antibacterial Susceptibility
25%
Clinical Characteristics
24%
Antibiotics
24%
University Hospital
24%
Clinical Microbiology
23%
Ventilator-associated Pneumonia
23%
Clarithromycin
23%
Chemotherapy
23%
Pulmonary Infection
22%
Bacterial Respiratory Pathogens
22%
Japanese Society
22%
Nationwide Surveillance
22%
Minimum Inhibitory Concentration
22%
Molecular Diagnostics
21%
Community-acquired Pneumonia
21%
Legionella Pneumophila
20%
Acute Respiratory Tract Infection
20%
Carbapenems
20%
Respiratory Infection
20%
Antimicrobial Susceptibility
18%
Neutralizing Antibodies
18%
Viral Load
18%
Influenza-like Illness
18%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Methicillin-Resistant Staphylococcus Aureus
65%
Pseudomonas aeruginosa
65%
Penicillinase
50%
SARS Coronavirus
48%
Azithromycin
38%
Mucin 5AC
37%
Macrolide
33%
Respiratory Tract Infection
32%
Antiinfective Agent
30%
Disease
30%
Infectious Agent
29%
Quinolone Derivative
29%
Mouse Model
28%
Vancomycin
27%
Streptococcus
24%
Methicillin Resistant Staphylococcus Aureus Infection
24%
Pharmacokinetics
23%
Haemophilus influenzae
21%
Meropenem
20%
Clarithromycin
18%
Ventilator Associated Pneumonia
18%
Lung Infection
17%
Antibiotics
17%
Lung Aspergillosis
16%
Coronavirinae
16%
Bloodstream Infection
16%
Legionella pneumophila
16%
Sitafloxacin
15%
Neutralizing Antibody
15%
Mucin
15%
Community Acquired Pneumonia
14%
Levofloxacin
14%
Quinolone
13%
Staphylococcus Aureus
12%
Ampicillin
12%
Amphotericin B
12%
Carbapenem Resistance
12%
Cytokine
12%
Linezolid
12%
Garenoxacin
12%
Aspergillus
11%
Respiratory Failure
11%
Penicillin Derivative
11%
Fusobacterium nucleatum
11%
Health Care Associated Pneumonia
11%
Biapenem
11%
Streptococcus Pneumonia
10%
Aspergillus fumigatus
10%
Chemotherapy
10%
Medicine and Dentistry
Infection
64%
COVID-19
40%
Penicillinase
33%
Pathogen
28%
Lung
27%
Antiinfective Agent
24%
Pseudomonas aeruginosa
23%
Methicillin Resistant Staphylococcus Aureus
22%
Severe Acute Respiratory Syndrome Coronavirus 2
22%
Respiratory Tract Infection
20%
Chemotherapy
18%
Community-Acquired Pneumonia
16%
Bloodstream Infection
16%
Pneumococcus
15%
Disease
15%
Health Care Associated Pneumonia
15%
Antibiogram
14%
Nucleic Acid Test
13%
Meropenem
12%
Reverse Transcription Polymerase Chain Reaction
12%
Matrix-Assisted Laser Desorption-Ionization
12%
Respiratory Failure
12%
Diagnosis
12%
Vancomycin
12%
Antibiotics
11%
Clinical Feature
10%
Antibiotic Resistance
10%
Haemophilus influenzae
10%
Adult T-Cell Leukemia/Lymphoma
10%
Chronic Pulmonary Aspergillosis
10%
Peptoclostridium difficile
10%
Carbapenem
10%
Aeromonas
10%
Lung Aspergillosis
10%
Streptococcus constellatus
10%
Azithromycin
10%
Real Time Polymerase Chain Reaction
10%
Legionella pneumophila
10%
TNF Inhibitor
10%
Streptococcus Pneumonia
10%
Klebsiella pneumoniae
10%
Pneumococcal Infection
9%
Abscess
9%
Computer Assisted Tomography
8%
Pneumococcal Pneumonia
8%
Interleukin 6
8%
Staphylococcus Aureus
8%
Fusobacterium nucleatum
7%
Fulminant
7%
Agar
7%